The National Academy of Clinical Biochemistry is pleased to announce the winners of the 2012 Distinguished Abstracts Awards. A group of NACB Fellows selected these 32 abstracts for their scientific excellence from a pool of 888 abstracts accepted for the AACC Annual Meeting.
Winning abstracts will display the NACB blue ribbon during the AACC Annual Meeting poster sessions in Los Angeles, CA.
A-18 Jaroslav Racek, Pilsen, Czech Republic
Lipoprotein-associated phospholipase A2 in hemodialysis patients and its relation to their prognosis and other risk factors of cardiovascular diseases
A-34 Roy Peake, Boston, MA
High sensitivity troponin and 5 year mortality in hemodialysis patients
A-52 John Rodriguez, Benicia, CA
Improved uniformity in a serological assay for anti-Sm by treatment of Sm autoantigen with RNase
A-119 Kazuhiko Kotani, MD, PhD, Jichi Medical University, Shimotsuke-City, Tochigi, Japan
The association between fasting plasma glucose and serum oxidized high-density lipoprotein levels in patients with dyslipidemia
A-141 Werner Steimer, MD, Munich, Germany
The human melanocortin four receptor gene: A new candidate gene for second generation antipsychotic-related weight gain?
A-142 Ping Wang, PhD, The Methodist Hospital, Houston, TX
MiRNA profile associated with chronic calcineurin inhibitor nephrotoxicity in renal transplant biopsies
A-161 Mark Borgman, PhD, Louisville, KY
The SLC6A4 Long A>G polymorphism enhances the clinical sensitivity of SSRI poor-responder genotyping
B-130 Mei-Chia Wang, MS, Taoyuan County, Taiwan
Application of a PNA-clamping real-time PCR method to predict the response to tyrosine kinase inhibitors from pleural effusions of patients with non-small-cell lung cancer
C-09 Cecilia Fernandez, PhD, Lexington, MA
Next-gen deep sequencing improves FGFR3 mutation detection in the urine of bladder cancer patients
C-25 Andreas Scorilas, PhD, Athens, Greece
Kallikrein-related peptidase 4 (KLK4) mRNA expression: a novel molecular tissue biomarker for the prediction of short-term relapse in colorectal adenocarcinoma
C-27 Emmanuel Fragoulis, PhD, University of Athens, Athens, Greece
miR-145 and its target, L-Dopa Decarboxylase (DDC), are promising prognostic biomarkers for the disease-free survival of prostate cancer patients
C-52 Lia Back, Florianópolis, Brazil
Association between an obesity-related gene and breast cancer risk
C-57 Brian Netzel, Mayo Clinic, Rochester, MN
Examination of thyroglobulin iodination states and quantitative usefulness for clinical thyroid cancer diagnostics
C-128 Mikio Watanabe, MD, PhD, Suita, Japan
Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease
C-141 Torsten Matthias, PhD, Oakland, CA
Biomarker for spondyloarthritis: Autoantibodies against Class II-associated invariant chain peptide (CLIP)
C-193 Yves Giguère, MD, PhD, Québec, QC Canada
Candidate clinical factors and biomarkers for early prediction of preeclampsia: performance of a multivariate algorithm in a low-risk population
D-53 Zachary Godwin, Davis, CA
Hematocrit effects lead to inadequate glycemic control and insulin dosing in adult burn patients
D-79 Eduardo Martínez Morillo, PhD, Toronto, ON Canada
Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage
D-98 Alexander Gilmanov, MD, PhD, Russian Federation
NGAL vs. other biomarkers of kidney injury during lithotripsy
D-107 Douglas Stickle, PhD, Jefferson University Hospital, Philadelphia, PA
Receiver-operator characteristics of adjusted urine oxycodone measurements to distinguish between three different rates of drug administration
D-128 Ashley Ward, MD, Boston, MA
Free phenytoin: to measure or to calculate?
E-04 Ioannis Papassotiriou, PhD, Athens, Greece
Association of inflammation, endothelial dysfunction and angiogenesis in patients with thalassemia intermedia
E-20 Amy Pyle, PhD, Nationwide Children’s Hospital, Columbus, OH
Development and implementation of a method to measure hemoglobin in dried blood spots
E-26 Archana Agarwal, MD, Salt Lake City, UT
Identification of low concentration of Hb H by isoelectric focusing in alpha thalassemia with one or two alpha chain deletions
E-44 Jane Dickerson, PhD, University of Washington, Seattle, WA
A door not closed: a systematic review of unacknowledged send-out results
E-60 Jackie Coleman, PhD, Accumetrics, San Diego, CA
An economic model incorporating a point of care platelet function assay: a quality improvement and value assessment tool
E-65 Lei Stones Chen, University of Washington, Seattle, WA
A web-based route planning tool for transporting laboratory specimens
E-159 Erna Lenters-Westra, Zwolle, Netherlands
Interpretation of hemoglobin A1c values among different health care professionals
E-167 Jennifer McDonald, PhD, Mayo Clinic, Rochester, MN
Has the incidence of intravenous contrast induced nephropathy been overestimated?
E-179 Konstantinos Makris, PhD, Athens, Greece
Glial Fibrillary Acidic Protein (GFAP) levels on admission differentiate between ischemic stroke (IS) and intracerebral hemorrhage (ICH) and correlate with severity and outcome among ICH patients
E-185 John Kalns, PhD, San Antonio, TX
Search for a novel salivary biomarker candidate for with chronic fatigue syndrome
E-202 Eberhard Spanuth, Heidelberg, Germany
Incremental prognostic value of High-Sensitivity Troponin T in mortality risk prediction of stable coronary artery disease